Westermann 2016
|
77 women undergoing vaginal hysterectomy with prolapse repairs
|
Intervention cotton gauze (2”*15’), that was tightly packed
into the vagina at the completion of the surgical procedure
Control no packing
Co-intervention(s) all women received controlled analgesia for
breakthrough pain as required and had indwelling transurethral catheters
overnight
|
Primary
· Pain (vas 0 (no pain) to 100 (severe pain))
Secondary
· Satisfaction after surgery (vas 0 (no satisfied) to 100 (very
satisfied))
· Bother attributable to the vaginal packing (vas 0 (not bothersome) to
100 (very bothersome))
· Postoperative vaginal blood loss
|
Randomization
Low risk (sequential number randomization concealed by sealed, opaque
envelopes)
Blinding
Low risk (participants and outcome assessors were blinded to the
intervention, all women responded to vas assessments)
Follow up, Complete
Other, n/a
Overall, low risk
|
Thiagamoorthy 2013
|
173 women undergoing vaginal hysterectomy with prolapse repairs
|
Intervention cotton gauze (7.5 m*10 cm) soaked in proflavine
antiseptic solution, that was tightly packed into the vagina at the
completion of the surgical procedure
Control no packing
Co-intervention(s) all women had an indwelling Foley catheter
until the following morning and received analgesia for breakthrough pain
Surgeons could decide to place a pack at discretion regardless of the
randomization
|
Primary
· Pain (short-form McGill Pain Questionnaire)
Secondary
· Infective and haematological postoperative morbidity
|
Randomization
Low risk (randomization concealed by sealed envelopes)
Blinding
Low risk (participants and outcome assessors were blinded to the
intervention, responded questionnaires before packing removal)
Follow up, Complete
Other, n/a
Overall, low risk
|
Urzua 2013
|
144 women undergoing vaginal hysterectomy
|
Intervention gauze soaked in povidone iodine for 24 h.
Control no packing
Co-intervention(s) all women received antibiotic prophylaxis
(cefazolin, 1 g i.v.), had an indwelling Foley catheter for 24 h and
received analgesia for breakthrough pain
|
Primary
· Postoperative vaginal blood loss
Secondary
· Pain (vas 0 (no pain) to 10 (severe pain))
· Postoperative complications (DINDO II or higher)
|
Randomization
Unclear (described as randomized)
Blinding
Unclear (blinded outcome assessment reported)
Follow up, Unclear
Other trial reported as conference abstract
Overall unclear risk
|
Baumgarten 2010
|
43 women undergoing vaginal surgery
|
Intervention vaginal packing
Control no packing
Co-intervention(s) not described
|
· Postoperative complications (bleeding or infection)
The trial report did not discriminate primary or secondary
outcomes
|
Randomization
Unclear (described as randomized)
Blinding
High (described as open trial)
Follow up, Unclear
Other, trial reported as conference abstract
Overall, unclear risk
|